Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00061282Phase 2Terminated
Phase 2, randomised, double-blind trial of clotrimazole in pouchitis (6 cohorts), sponsored by Web Industries. Primary endpoint: Improvement in Pouchitis Disease Activity Index at 30 Days. Started Sep 2002; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00061282.